The association between a decrease in on-treatment neutrophil-to-eosinophil ratio (ner) at week 6 after ipilimumab plus nivolumab initiation and improved clinical outcomes in metastatic renal cell carcinoma

HIGHLIGHTS

• who: Yu-Wei Chen et al. from the Division of Hematology Oncology, Vanderbilt University Medical Center, Medical Center Drive, Nashville, TN, USA have published the paper: The Association between a Decrease in On-Treatment Neutrophil-to-Eosinophil Ratio (NER) at Week 6 after Ipilimumab Plus Nivolumab Initiation and Improved Clinical Outcomes in Metastatic Renal Cell Carcinoma, in the Journal: (JOURNAL) of 21/08/2021
• what: This study investigated the decrease in NER at week 6 after ipilimumab/nivolumab (ipi/nivo) initiation and treatment responses in mRCC. Landmark analysis was conducted to investigate the association between . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.